Bradley Foster & Sargent Inc. CT Has $1.38 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Bradley Foster & Sargent Inc. CT decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,412 shares of the financial services provider’s stock after selling 250 shares during the period. Bradley Foster & Sargent Inc. CT’s holdings in iShares Biotechnology ETF were worth $1,377,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Darwin Wealth Management LLC bought a new position in iShares Biotechnology ETF during the third quarter worth about $29,000. Highline Wealth Partners LLC acquired a new stake in iShares Biotechnology ETF during the third quarter worth approximately $30,000. HHM Wealth Advisors LLC lifted its position in iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $138.91 on Friday. The firm has a 50 day moving average price of $135.61 and a two-hundred day moving average price of $140.77. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.